L. Lupo

2.8k total citations
48 papers, 1.7k citations indexed

About

L. Lupo is a scholar working on Surgery, Hepatology and Oncology. According to data from OpenAlex, L. Lupo has authored 48 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Surgery, 18 papers in Hepatology and 16 papers in Oncology. Recurrent topics in L. Lupo's work include Hepatocellular Carcinoma Treatment and Prognosis (10 papers), Liver Disease and Transplantation (7 papers) and Organ Transplantation Techniques and Outcomes (7 papers). L. Lupo is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (10 papers), Liver Disease and Transplantation (7 papers) and Organ Transplantation Techniques and Outcomes (7 papers). L. Lupo collaborates with scholars based in Italy, United States and United Kingdom. L. Lupo's co-authors include Gianluigi Giannelli, Salvatore Antonaci, Francesco Dituri, V. Memeo, Emilia Fransvea, Antonio Mazzocca, Michele Quaranta, Felice Marinosci, Serena Mancarella and Carlo Bergamini and has published in prestigious journals such as Blood, Hepatology and Radiology.

In The Last Decade

L. Lupo

48 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L. Lupo Italy 23 624 580 521 417 359 48 1.7k
Michiyoshi Hisanaga Japan 22 475 0.8× 439 0.8× 632 1.2× 691 1.7× 257 0.7× 55 1.7k
Shouxian Zhong China 21 430 0.7× 325 0.6× 454 0.9× 370 0.9× 295 0.8× 75 1.5k
Atsunori Tsuchiya Japan 25 886 1.4× 710 1.2× 307 0.6× 715 1.7× 307 0.9× 130 2.2k
Joachim C. Mertens Switzerland 24 724 1.2× 502 0.9× 733 1.4× 850 2.0× 314 0.9× 69 2.3k
Toru Mizuguchi Japan 26 934 1.5× 462 0.8× 539 1.0× 1.1k 2.6× 198 0.6× 128 2.1k
Masahiro Ohira Japan 22 502 0.8× 415 0.7× 572 1.1× 491 1.2× 192 0.5× 185 2.0k
Miroslaw Kornek Germany 22 347 0.6× 747 1.3× 280 0.5× 226 0.5× 453 1.3× 48 1.6k
Brigitte Bancel France 22 581 0.9× 411 0.7× 222 0.4× 494 1.2× 263 0.7× 68 1.6k
Jianye Cai China 23 262 0.4× 975 1.7× 388 0.7× 318 0.8× 569 1.6× 39 1.9k
Eizaburo Sasatomi United States 26 452 0.7× 321 0.6× 500 1.0× 591 1.4× 187 0.5× 77 1.8k

Countries citing papers authored by L. Lupo

Since Specialization
Citations

This map shows the geographic impact of L. Lupo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Lupo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Lupo more than expected).

Fields of papers citing papers by L. Lupo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Lupo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Lupo. The network helps show where L. Lupo may publish in the future.

Co-authorship network of co-authors of L. Lupo

This figure shows the co-authorship network connecting the top 25 collaborators of L. Lupo. A scholar is included among the top collaborators of L. Lupo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Lupo. L. Lupo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dituri, Francesco, Tannin A. Schmidt, Serena Mancarella, et al.. (2020). Proteoglycan-4 is correlated with longer survival in HCC patients and enhances sorafenib and regorafenib effectiveness via CD44 in vitro. Cell Death and Disease. 11(11). 984–984. 20 indexed citations
2.
Rani, Bhavna, Andrea Malfettone, Francesco Dituri, et al.. (2018). Galunisertib suppresses the staminal phenotype in hepatocellular carcinoma by modulating CD44 expression. Cell Death and Disease. 9(3). 373–373. 39 indexed citations
3.
Simone, Valeria De, Oronzo Brunetti, L. Lupo, et al.. (2017). Targeting Angiogenesis in Biliary Tract Cancers: An Open Option. International Journal of Molecular Sciences. 18(2). 418–418. 52 indexed citations
4.
Cao, Yuan, Rahul Agarwal, Francesco Dituri, et al.. (2017). NGS-based transcriptome profiling reveals biomarkers for companion diagnostics of the TGF-β receptor blocker galunisertib in HCC. Cell Death and Disease. 8(2). e2634–e2634. 46 indexed citations
5.
Gnoni, Antonio, Daniele Santini, Mario Scartozzi, et al.. (2015). Hepatocellular carcinoma treatment over sorafenib: epigenetics, microRNAs and microenvironment. Is there a light at the end of the tunnel?. Expert Opinion on Therapeutic Targets. 19(12). 1623–1635. 56 indexed citations
6.
7.
Dituri, Francesco, Antonio Mazzocca, L. Lupo, et al.. (2011). PI3K class IB controls the cell cycle checkpoint promoting cell proliferation in hepatocellular carcinoma. International Journal of Cancer. 130(11). 2505–2513. 36 indexed citations
8.
Trerotoli, Paolo, Emilia Fransvea, L. Lupo, et al.. (2009). Tissue expression of Squamous Cellular Carcinoma Antigen (SCCA) is inversely correlated to tumor size in HCC. Molecular Cancer. 8(1). 29–29. 24 indexed citations
9.
Lupo, L., Francesco Tandoi, Gianluigi Giannelli, et al.. (2008). Basiliximab Versus Steroids in Double Therapy Immunosuppression in Liver Transplantation: A Prospective Randomized Clinical Trial. Transplantation. 86(7). 925–931. 37 indexed citations
10.
Lupo, L., et al.. (2007). Single hepatocellular carcinoma ranging from 3 to 5 cm: radiofrequency ablation or resection?. HPB. 9(6). 429–434. 71 indexed citations
11.
Bergamini, Carlo, Concetta Sgarra, Paolo Trerotoli, et al.. (2007). Laminin-5 stimulates hepatocellular carcinoma growth through a different function of α6β4 and α3β1 integrins. Hepatology. 46(6). 1801–1809. 64 indexed citations
12.
Cicco, Giuseppe De, et al.. (2005). Solutions for Organ Perfusion and Storage: Haemorheologic Aspects. Transplantation Proceedings. 37(6). 2456–2458. 6 indexed citations
13.
Giannelli, Gianluigi, Felice Marinosci, Concetta Sgarra, et al.. (2005). Clinical role of tissue and serum levels of SCCA antigen in hepatocellular carcinoma. International Journal of Cancer. 116(4). 579–583. 54 indexed citations
14.
Cicco, Giuseppe De, Riccardo Memeo, G Catalano, et al.. (2005). MELD Predictive Value of Alterations of Brain Perfusion During Liver Transplantation. Transplantation Proceedings. 37(6). 2622–2625. 3 indexed citations
15.
Lupo, L., et al.. (2003). [Anatomical hepatic resection using radiofrequency thermoablation in the treatment of primary or secondary liver tumors].. PubMed. 89(4 Suppl). 105–6. 7 indexed citations
16.
Vendemiale, Gianluigi, Ignazio Grattagliano, L. Lupo, V. Memeo, & E. Altomare. (2002). Hepatic oxidative alterations in patients with extra-hepatic cholestasis. Effect of surgical drainage. Journal of Hepatology. 37(5). 601–605. 53 indexed citations
17.
Giannelli, Gianluigi, Carlo Bergamini, Felice Marinosci, et al.. (2001). Clinical role of MMP‐2/TIMP‐2 imbalance in hepatocellular carcinoma. International Journal of Cancer. 97(4). 425–431. 168 indexed citations
18.
Lupo, L., Jacques Pirenne, Bridget Gunson, et al.. (1997). Acute pancreatitis after orthotopic liver transplantation. Transplantation Proceedings. 29(1-2). 473–473. 15 indexed citations
19.
Lupo, L., et al.. (1996). Improved accuracy of computed tomography in local staging of rectal cancer using water enema. International Journal of Colorectal Disease. 11(2). 60–64. 12 indexed citations
20.
Baruchin, A.M., Amir Sagi, L. Lupo, & Daniel J. Hauben. (1984). Cutaneous horn (cornu cutaneum).. PubMed. 6(4). 355–7. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michiyoshi Hisanaga Breakdown of academic impact, for papers by Shouxian Zhong Breakdown of academic impact, for papers by Atsunori Tsuchiya Breakdown of academic impact, for papers by Joachim C. Mertens Breakdown of academic impact, for papers by Toru Mizuguchi Breakdown of academic impact, for papers by Masahiro Ohira Breakdown of academic impact, for papers by Miroslaw Kornek Breakdown of academic impact, for papers by Brigitte Bancel Breakdown of academic impact, for papers by Jianye Cai Breakdown of academic impact, for papers by Eizaburo Sasatomi
Rankless by CCL
2026